GGrantIndex
Sort

8,912 grants matching sars cov 2

Rapid and efficient generation of sequence variants by templated synthesis

$452,375
Harris H Wang · Columbia University Health Sciences · R21 · FY2023 · HG

Optimization of Cu(II)-ligand catalysts, membrane materials, and coatings for O2-tolerant, portable, and low-cost electrochemical nitric oxide generation devices/catheters

$452,261
Nicolai Lehnert · University Of Michigan At Ann Arbor · R01 · FY2025 · HL

Structural and mechanistic study of bat NLRP6 inflammasome in detecting RNA viruses

$451,836
Chen Shen · Washington University · R01 · FY2025 · AI

Crossing scales to predict and prevent bat virus zoonoses in a Madagascar ecosystem

$451,808
Cara Brook · University Of Chicago · DP2 · FY2024 · AI

Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based  assay to reveal novel T cell subsets in SARS-CoV-2 infected patients

$451,729
Jonathan D Powell · Johns Hopkins University · U54 · FY2022 · CA

Computational Chemistry and Macromolecular Modeling

$451,465
William Copeland · National Institute Of Environmental Health Sciences · ZIC · FY2025 · ES

NOX1 and NOX2 as Therapeutic Targets in Influenza

$450,968
J. David Lambeth · Emory University · R33 · FY2016 · AI

Structure and Mechanism of HERC5-dependent ISGylation

$450,900
Donald Eric Spratt · Clark University (Worcester, Ma) · R15 · FY2022 · GM

Systems Biology Modeling of Severe Community-Acquired Pneumonia

$450,838
Richard G Wunderink · Northwestern University At Chicago · U19 · FY2025 · AI

Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection

$450,752
Monica Kraft · University Of Arizona · U19 · FY2022 · AI

Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery

$450,520
James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR

SARS-CoV-2 and Influenza Infection in the Syrian Hamster

$450,500
Caroline J Zeiss · Yale University · R21 · FY2020 · AI

Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV

$450,462
Ralph S Baric · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI

Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19

$450,305
Lu Peng · Louisiana State Univ A&M Col Baton Rouge · U01 · FY2021 · AA

Development of highly neutralizing nanobodies against HIV-1, SARS-CoV-2 and other pathogens

$450,282
John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR

COVID-19 research efforts

$450,222
Thomas Waldmann · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

PIPP Phase I: Develop and Evaluate Computational Frameworks to Predict and Prevent Future Coronavirus Pandemics

$450,189
Hong Qin · Old Dominion University Research Foundation · · FY2024 · CSE

Factors Responsible for the Development of Post-Acute Sequelae of Acute COVID Infection (PASC) In Hawaii

$450,115
Gehan Devendra · University Of Hawaii At Manoa · U54 · FY2025 · MD

Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample

$450,000
Xiaohu Yao · Atom Bioworks Inc · R44 · FY2022 · DE

Biochemistry of SARS-CoV-2 Spike Protein and its Ocular Surface Membrane Receptor

$449,897
Thomas Redmond · National Eye Institute · ZIA · FY2021 · EY

CRISPR-Cas13-based rapid HIV-1 test

$449,888
Peter B Lillehoj · Rice University · R61 · FY2024 · AI

Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy

$449,809
Gulin Oz · University Of Minnesota · R01 · FY2023 · NS

Integrated Exchange and Storage of Current- and Future-Generation Immunogenomic Data

$449,783
Steven John Mack · University Of California, San Francisco · R01 · FY2023 · AI

Integrated Exchange and Storage of Current- and Future-Generation Immunogenomic Data

$449,783
Steven John Mack · University Of California, San Francisco · R01 · FY2025 · AI

Integrated Exchange and Storage of Current- and Future-Generation Immunogenomic Data

$449,783
Steven John Mack · University Of California, San Francisco · R01 · FY2024 · AI